beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - Villanueva, C; Albillos, A; Genesca, J (Lancet, 2019)
et al.